🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

211 results for “Jian” Clear

  1. Bupivacaine Liposome Injection

    Jian Li

    Local Analgesia Via Infiltration

    approved small molecule active

    1 trial

  2. Ceftolozane/tazobactam

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Bronchiectasis

    approved small molecule active

    1 trial

  3. EPIAO®

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Anaemia

    approved small molecule terminated

    1 trial

  4. Sulforaphane

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    HIV Infections

    approved small molecule active

    1 trial

  5. TPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    ITP

    approved small molecule completed

    1 trial

  6. rhTPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Previously Treated Primary Immune Thrombocytopenia

    approved small molecule completed

    1 trial

  7. tong-jiang granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome

    approved small molecule active

    1 trial

  8. Basic treatment

    Jian Li

    Major Depressive Disorder

    small molecule completed

    1 trial

  9. Conventional Artificial Cycle Therapy

    Jian Li

    Infertility, Female

    small molecule active

    1 trial

  10. Da Jian Zhong Tang (Zanthoxylum, Ginger, Ginseng, Maltose)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ERAS

    small molecule active

    1 trial

  11. Doxycycline

    Jian Li

    Amyloidosis; Systemic

    small molecule completed

    1 trial

  12. Experimental

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Cognitive Health

    other completed

    1 trial

  13. Inhaled corticosteriod/long-acting beta-agonist plus Montelukast

    Second Affiliated Hospital, School of Medicine, Zhejiang University

    Asthma

    small molecule active

    1 trial

  14. Jianpixiaozhong particles and Wuse Dietotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Idiopathic Membranous Nephropathy

    small molecule active

    1 trial

  15. MINGO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    X-Linked Dystonia Parkinsonism

    other completed

    1 trial

  16. PROGRAM

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Obesity

    other completed

    1 trial

  17. Power Line Program

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Metabolic Health

    other completed

    1 trial

  18. Radiotherapy combined with TKI and Anti-PD-1 Antibody

    Jian Li

    Stage IIIA Hepatocellular Carcinoma

    other active

    1 trial

  19. Redefine

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Obesity & Overweight

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources